Quantcast

Tag Archives: Premarin

Prempro plaintiff can’t show causation, District Court rules

A product liability plaintiff could not show that the alleged failure of pharmaceutical companies to warn about the dangers of their hormone therapy drugs was the proximate cause of her breast cancer, a U.S. District Court in South Carolina has ...

Read More »

Pa. court reinstates $28M punitive award in HRT case

A $28 million award of punitive damages was not unconstitutionally excessive in a product liability case brought by a woman who contracted breast cancer after taking hormone replacement therapy drugs, a Pennsylvania appellate court has ruled in reversing judgment.

Read More »

Prempro breast cancer cases settle after jury awards $76 million

After a jury in Philadelphia awarded $76 million in compensatory damages to three women who claimed that the hormone therapy drugs Prempro, Premarin and Provera caused their breast cancer, drug maker Wyeth Pharmaceuticals settled the cases for a confidential amount.

Read More »

Plaintiff’s expert can’t testify in Prempro case

A treating physician could not testify as an expert in a product liability lawsuit alleging that the plaintiff’s breast cancer was caused by her ingestion of hormone replacement therapy drugs, a U.S. District Court in West Virginia has ruled.

Read More »

Drug litigation in review 2010

Much like 2009, 2010 was a busy year for prescription drug suits.

Read More »